Abstract
Cardiovascular diseases (CVD) is one of the commonest causes of mortality affecting both sexes worldwide. It is expected that by 2020, CVD would prevail as the foremost cause of fatality and disability over infectious diseases globally. The estimation of lipids, lipoproteins has long been recognized as indispensable for the diagnosis and clinical management of disorders of lipoprotein metabolism. On the basis of this, the present study evaluation of variation in the lipid profile and conventional risk factors in patients with coronary artery disease was performed. The present hospital based cross-sectional study was conducted in Department of Biochemistry, MMIMSR, Mullana, Ambala on 426 subjects over a period of two years. Blood was collected from the subjects after an overnight fast of 12 hours and estimation of lipid profile, Lp(a),and fasting blood glucose was done. Conclusion: It is difficult to predict which individual with dyslipidaemia will develop CHD; early detection, evaluation and aggressive treatment are vital components of the strategies to control CHD. It is advised to correct the anticipatory factors such as diet, exercise, weight loss and smoking cessation, in order to lessen the toll from heart diseases.
